Importing Pharmaceutical APIs into South Korea: A Buyer’s Sourcing Guide

Buyers importing pharmaceutical APIs into South Korea for the first time usually ask the wrong first question — “can you ship here” — when the real gating factor is almost always documentation, not logistics. South Korea’s MFDS runs one of the more rigorous approval processes in Asia, and Korean formulators importing API from India typically do so for specific molecules where domestic or Japanese supply is either unavailable or priced well above Indian manufacturing costs.

What South Korea’s Regulator Actually Requires

MFDS (Ministry of Food and Drug Safety) is the national authority governing pharmaceutical imports into South Korea. In practice, that means every shipment needs to carry a Certificate of Analysis specific to the batch, a Material Safety Data Sheet, and a current WHO-GMP certificate from the manufacturing site. Depending on the registration pathway your import falls under, you may also need a Drug Master File reference number or a Certificate of Suitability — ask for these upfront rather than assuming a supplier’s general “GMP certified” claim covers it.

Realistic Shipping Timeline

Standard delivery to South Korea is 7-12 business days by air freight, 25-30 days by sea. That’s freight time only. Add whatever your own import registration, customs clearance, or local broker process takes on the South Korea side — that part is outside any exporter’s control and varies more between individual shipments than the freight leg does.

What Actually Causes Delays

Most of the friction that shows up after an order is placed isn’t about the manufacturing or freight stage — it’s HS code misclassification at customs, a buyer who hasn’t yet secured the import license or registration their own country requires, or documentation that’s incomplete on the first submission and has to go back and forth. All three are avoidable by confirming the paperwork before the shipment leaves India, not after it arrives.

Choosing a Verified Supplier

Aarise Pharma is a WHO-GMP certified pharmaceutical API manufacturer based in Haridwar, India, supplying buyers in South Korea with bulk APIs and third-party manufactured dispersible tablet formulations, each shipment backed by a Certificate of Analysis and full regulatory documentation. Full product categories, quality documentation, and country-specific shipping detail are on the Pharmaceutical API Supplier for South Korea — WHO-GMP Export from India page.

Frequently Asked Questions

What documentation does a buyer in South Korea need for a bulk API import from India?

At minimum, a batch-specific Certificate of Analysis, an MSDS, and WHO-GMP certification from the manufacturer. MFDS (Ministry of Food and Drug Safety) is the national authority governing pharmaceutical imports into South Korea. Beyond that, a DMF or CEP reference is usually needed depending on the specific registration pathway your import falls under.

How long does shipping to South Korea actually take?

Standard delivery to South Korea is 7-12 business days by air freight, 25-30 days by sea.

Why do buyers in South Korea import bulk API from India rather than sourcing locally?

South Korea’s MFDS runs one of the more rigorous approval processes in Asia, and Korean formulators importing API from India typically do so for specific molecules where domestic or Japanese supply is either unavailable or priced well above Indian manufacturing costs.

Does Aarise Pharma supply directly to South Korea?

Yes. Aarise Pharma is a WHO-GMP certified manufacturer supplying bulk APIs and third-party manufactured formulations to buyers in South Korea, with a Certificate of Analysis, MSDS, and full regulatory documentation on every shipment. See the Pharmaceutical API Supplier for South Korea — WHO-GMP Export from India page for the full product range and country-specific detail.